
News|Articles|April 25, 2008
Biovail receives approval for Aplenzin for depression
Aplenzin is a new drug from Biovail Corp. that has been approved to treat depression in adults
Advertisement
Aplenzin (bupropion hydrobromide), formerly known as BVF-033, is an antidepressant from Biovail Corp. that has just received approval from the Food & Drug Administration. The
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Severe COVID-19 Increases Stroke Risk for Patients With Asthma
2
Coming Full Circle: How Mike Brundage Built a Thriving Pharmacy in Rural Pennsylvania
3
FDA Approves First 1-Minute Self Test for HIV
4
Pharmacists Help Patients Stay Adherent to COPD Therapy, Improving Overall Quality of Life
5